EDP-305, A Novel and Potent Farnesoid X Receptor Agonist, Exhibits Favorable Anti-inflammatory and Anti-fibrotic Activity In Vitro

被引:0
|
作者
Li, Yang [1 ]
Chau, Mary D. [1 ]
Wang, Guoqiang [1 ]
Or, Yat Sun [1 ]
Jiang, Lijuan [1 ]
机构
[1] Enanta Pharmaceut Inc, Watertown, MA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1596
引用
收藏
页码:791A / 791A
页数:1
相关论文
共 50 条
  • [1] EDP-305, A SELECTIVE FARNESOID X RECEPTOR AGONIST, EXHIBITS EXCELLENT POTENCY IN VITRO AND IN VIVO AND ANTI-FIBROTIC EFFECT IN VITRO
    Li, Yang
    Chau, Mary
    Or, Yat Sun
    Jiang, Li-Juan
    GASTROENTEROLOGY, 2018, 154 (06) : S1159 - S1159
  • [2] EDP-305, A Novel and Highly Potent Farnesoid X Receptor Agonist, Exerts Favorable Effects on Lipid Metabolism In Vitro
    Li, Yang
    Chau, Mary D.
    Wang, Guoqiang
    Or, Yat Sun
    Jiang, Lijuan
    HEPATOLOGY, 2016, 64 : 779A - 779A
  • [3] EDP-305, A Novel and Selective Farnesoid X Receptor Agonist, Exhibits high Potency and Efficacy In Vitro and In Vivo
    Li, Yang
    Chau, Mary D.
    Wang, Guoqiang
    Or, Yat Sun
    Jiang, Lijuan
    HEPATOLOGY, 2016, 64 : 767A - 767A
  • [4] Significant anti-fibrotic efficacy of EDP-305, a highly potent and selective farnesoid X receptor (FXR) agonist, in a rat model of thioacetamide-induced liver fibrosis and cirrhosis
    Jiang, Li-Juan
    Bhattacharya, Dipankar
    Chou, Hsin I.
    Chau, Mary D.
    Li, Yang
    Or, Yat Sun
    Friedman, Scott L.
    HEPATOLOGY, 2017, 66 : 90A - 90A
  • [5] TISSUE DISTRIBUTION OF EDP-305, A HIGHLY SELECTIVE AND POTENT FARNESOID X RECEPTOR (FXR) AGONIST, IN PRECLINICAL SPECIES
    Huang, Meng
    Jiang, Li-Juan
    Dai, Peng
    Ronsheim, Matthrew
    Or, Yat Sun
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S34 - S34
  • [6] A novel farnesoid X receptor agonist: EDP-305, reduces fibrosis progression in animal models of fibrosis
    Erstad, D. J.
    Farrar, C. T.
    Masia, R.
    Ferreira, D. D. S.
    Wei, L.
    Choi, J. -K.
    Ghoshal, S.
    Rotile, N.
    Li, Y.
    Chau, M.
    Tanabe, K. K.
    Or, Y. S.
    Caravan, P.
    Jiang, L. -J.
    Fuchs, B. C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S165 - S165
  • [7] EDP-305, a highly selective and potent farnesoid X receptor agonist, favorably regulates the expression of key fibrogenic genes in vitro and in vivo
    Li, Y.
    Shang, J.
    Chau, M.
    Roqueta-Riverta, M.
    Garlick, K.
    An, P.
    Vaid, K.
    Popov, Y.
    Or, Y. S.
    Jiang, L.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S398 - S398
  • [8] Molecular Magnetic Resonance Imaging Accurately Measures the Antifibrotic Effect of EDP-305 a Novel Farnesoid X Receptor Agonist
    Erstad, Derek J.
    Farrar, Christian T.
    Ghoshal, Sarani
    Masia, Ricard
    Ferreira, Diego S.
    Chen, Yin-Ching Iris
    Choi, Ji-Kyung
    Wei, Lan
    Waghorn, Phillip A.
    Rotile, Nicholas J.
    Tu, Chuantao
    Graham-Oregan, Katherine A.
    Sojoodi, Mozhdeh
    Li, Shen
    Li, Yang
    Wang, Guogiang
    Corey, Kathleen E.
    Or, Yat Sun
    Jiang, Lijuan
    Tanabe, Kenneth K.
    Caravan, Peter
    Fuchs, Bryan C.
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (07) : 821 - 835
  • [9] The Novel Farnesoid X Receptor (FXR) agonist, EDP-305, Reduces Fibrosis Progression in Bile Duct Ligated Rats
    Farrar, Christian T.
    Wei, Lan
    Choi, Ji-Kyung
    Huang, Shuning
    Ferriera, Diego Dos Santos
    Ghoshal, Sarani
    Masia, Ricard
    Li, Yang
    Chau, Mary D.
    Tanabe, Kenneth K.
    Or, Yat Sun
    Caravan, Peter
    Jiang, Lijuan
    Fuchs, Bryan C.
    HEPATOLOGY, 2016, 64 : 323A - 323A
  • [10] A NOVEL FARNESOID X RECEPTOR (FXR) AGONIST, EDP-305, REDUCES FIBROSIS PROGRESSION IN ANIMAL MODELS OF HEPATOBILIARY INJURY
    Erstad, Derek J.
    Farrar, Christian T.
    Masia, Ricard
    Dos Santos, Diego
    Choi, Ferreira Ji-Kyung
    Ghoshal, Sarani
    Rotile, Nicholas
    Li, Yang
    Chau, Mary
    Tanabe, Kenneth K.
    Or, Yat Sun
    Caravan, Peter
    Jiang, Li-Juan
    Fuchs, Bryan C.
    GASTROENTEROLOGY, 2017, 152 (05) : S1276 - S1276